EFFECT OF BLOODLETTING IN SKIN DISEASE
Phase 2
- Conditions
- Health Condition 1: L309- Dermatitis, unspecified
- Registration Number
- CTRI/2022/04/042100
- Lead Sponsor
- Muhammed Safeeque EK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subjects diagnosed with vicharchika having any three of kandu, shyava, srava and pidaka in lower limb
Exclusion Criteria
1. Subjects having acute inflammatory and infective condition
2. Subjects having uncontrolled DM, HTN
3. Subjects having cardiovascular disease
4. Subjects with positive HIV, HBsAg and VDRL.
5. Subjects with hemorrhagic disorders
6. Anemic subjects
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in subjective symptoms â?? itching, <br/ ><br>Reduction in objective findings- hyper pigmentation, oozing, vesication <br/ ><br>Timepoint: 0th day and 22nd day
- Secondary Outcome Measures
Name Time Method Changes in local blood parameters - - Hb, TWBC, DC, TRBC, Total platelet count, CT, BT, ESR, CRP, pO2, Pco2 and pHTimepoint: 0 TH DAY AND 22 ND DAY